« Previous
Next »
Titles
- CAPABLE: a model of empowering older adults to remain independent1
- CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters1
- CBO's Medicare beneficiary cost-sharing model: a technical description1
- CBO's long-term Social Security projections: changes since 2017 and comparisons with the Social Security trustees' projections1
- CBO's long-term Social Security projections: changes since 2018 and comparisons with the Social Security trustees' projections1
- CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act1
- CBO's simulation model of new drug development1
- CBO’s 2023 long-term budget projections: presentation at the American Enterprise Institute : methodologies in fiscal, economic, and health spending projections1
- CBO’s 2023 long-term projections for Social Security1
- CBO’s Medicaid baseline forecast1
- CBO’s analysis of the long-term budgetary outlook: presentation at the University of Michigan’s 71st Annual Economic Outlook Conference1
- CBO’s role and most recent long-term budget projections: presentation at a meeting of the National Conference of State Legislatures' budget working group1
- CDC found ways to use data to understand and address COVID-19 health disparities, despite challenges with existing data1
- CDC generally met its inspection goals for the federal select agent program: however, opportunities exist to strengthen oversight1
- CDC has improved the nursing home reporting process for COVID-19 Data in NHSN, but challenges remain1
- CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs1
- CDC’S Vaccines for Children program recipients did not conduct site visits at some providers as required1
- CDC’s internal control weaknesses led to its initial COVID-19 test kit failure, but CDC ultimately created a working test kit1
- CDER’s program for the recognition of voluntary consensus standards related to pharmaceutical quality: guidance for industry1
- CHIP enrollment: June 2012 data snapshot1